Augmedix, Inc. Common Stock
AUGX
AUGX was delisted on the 1st of October, 2024.
64 hedge funds and large institutions have $150M invested in Augmedix, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 6 closing their positions.
283% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 6
158% more call options, than puts
Call options by funds: $302K | Put options by funds: $117K
28% more funds holding
Funds holding: 50 → 64 (+14)
11% more capital invested
Capital invested by funds: $135M → $150M (+$14.9M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Samjo Capital
New York
|
+$6.63M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$2.23M |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$2.04M |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.76M |
| 5 |
GIPM
G2 Investment Partners Management
New York
|
+$1.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.79M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$1.08M |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$703K |
| 4 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$669K |
| 5 |
Renaissance Technologies
New York
|
-$340K |
AUGX Hedge Fund Activity: Q3 2023 in Review
64 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q3 2023, worth a combined $150M — up 11% from $135M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new AUGX positions and 6 closed out — a net gain of 17 holders — while 17 added to existing stakes and 17 trimmed.
The largest buyer was Samjo Capital, adding an estimated $6.63M. The largest seller was Point72 Asset Management, cutting an estimated $5.79M.
- 64 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q3 2023, up from 50 in Q2 2023.
- Funds reported $150M of Augmedix, Inc. Common Stock stock for Q3 2023, up 11% quarter-over-quarter.
- 23 funds opened new Augmedix, Inc. Common Stock positions in Q3 2023 and 6 closed out, a net change of +17 holders.
- The largest Augmedix, Inc. Common Stock buyer in Q3 2023 was Samjo Capital, an estimated $6.63M added.
- The largest Augmedix, Inc. Common Stock seller in Q3 2023 was Point72 Asset Management, an estimated $5.79M sold.
Based on aggregated 13F filings for Q3 2023.